Stock Screener App

Gratuito - Play StoreApp Store

Installare Installare

RLAY

$17.752.72%0.47

Relay Therapeutics Inc (RLAY)

Date: O: H: L: C: Vol:

Relay Therapeutics Inc Borsa (RLAY) Ultime notizie

RLAY Stock Technical Analysis - Pluang

Peter Rahmer Sells 753 Relay Therapeutics Shares at $18.62 to Cover RSU Tax Withholding - Kalkine Media

Form 4 Relay Therapeutics Inc: Peter Rahmer (Officer) For: 28 October - Investing.com UK

Relay Therapeutics officer Peter Rahmer sells $14,020 in shares - Investing.com

A 753-share sale covers stock-vesting taxes at Relay Therapeutics (RLAY). - Stock Titan

To cover taxes, Relay Therapeutics (RLAY) R&D president sells 2,252 shares. - Stock Titan

To cover vesting taxes, Relay Therapeutics (RLAY) CFO sells shares at $18.62. - Stock Titan

RLAY Stock Fundamentals & Key Ratios - Pluang

H.C. Wainwright raises target for Relay Therapeutics stock to USD 29 - ad-hoc-news.de

Relay Therapeutics officer proposes USD 1.81 million sale for Relay Therapeutics stock - ad-hoc-news.de

Relay Therapeutics officer proposes USD 1.81 million sale for Relay Therapeutics stock - ad-hoc-news.de

Form 4 Relay Therapeutics Inc For: 8 October By Investing.com - Investing.com Canada

Form 4 Relay Therapeutics Inc For: 8 October By Investing.com - Investing.com India

Relay Therapeutics CFO Catinazzo sells $329k in shares - Investing.com

Relay Therapeutics CEO Sanjiv Patel sells $872,401 company stock - Investing.com

Form 4 Relay Therapeutics Inc For: 8 October By Investing.com - Investing.com UK

Relay Therapeutics CFO Catinazzo sells $329k in shares By Investing.com - Investing.com UK

CEO sells 48,199 shares under a trading plan at Relay Therapeutics (RLAY). - Stock Titan

Under a trading plan, Relay Therapeutics (RLAY) CFO sells 17,511 shares plus 206 more. - Stock Titan

Relay Therapeutics CEO Sanjiv Patel sells $872,401 company stock By Investing.com - Investing.com UK

After two share sales, Sanjiv Patel proposes another at Relay Therapeutics (RLAY). - Stock Titan

After two 17,717-share sales, a Relay Therapeutics (RLAY) officer proposes another sale. - Stock Titan

Elevar Therapeutics Announces FDA Approval of Lyrfigtu (Lirafugratinib) as Second-line Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement Treatment Option - GlobeNewswire Inc.

Relay Therapeutics (Nasdaq:RLAY) - Stock Analysis - simplywall.st

Relay Therapeutics CEO Sanjiv Patel sells 48,199 shares for $912,889.06 - Bitget

Relay Therapeutics (RLAY) Insider Sell: President, R&D Donald Be - GuruFocus

Relay Therapeutics R&D president sells $161,814 in stock By Investing.com - Investing.com South Africa

Relay Therapeutics R&D president sells $161,814 in stock By Investing.com - Investing.com Nigeria

Relay Therapeutics R&D president sells $161,814 in stock - Investing.com

Relay Therapeutics R&D president sells $161,814 in stock By Investing.com - Investing.com India

Relay Therapeutics R&D president sells $161,814 in stock By Investing.com - Investing.com Canada

Relay Therapeutics Insider Sold Shares Worth $912,889, According to a Recent SEC Filing - marketscreener.com

Relay Therapeutics (RLAY) R&D chief sells stock under 10b5-1 plan - Stock Titan

Relay Therapeutics (RLAY) CFO sells about $335K in stock under preset plan - Stock Titan

Relay Therapeutics (NASDAQ: RLAY) CEO sells shares under preset trading plan - Stock Titan

Relay Therapeutics Insider Sold Shares Worth $912,889, According to a Recent SEC Filing - Yahoo Finance

Relay Therapeutics R&D president sells $161,814 in stock By Investing.com - Investing.com UK

Relay Therapeutics at Wells Fargo conference: pipeline nears key tests By Investing.com - Investing.com Canada

Relay Therapeutics at Wells Fargo conference: pipeline nears key tests By Investing.com - Investing.com UK

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September - news.futunn.com

Relay Therapeutics CFO Sells 17,717 Shares for $350,000 - Yahoo Finance

Relay Therapeutics CFO Sells 17,717 Shares for $350,000 - The Motley Fool

Relay Therapeutics to Participate in Upcoming September Healthcare Conference Fireside Chats - Quiver Quantitative

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September - GlobeNewswire

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September - finance.yahoo.com

Relay Therapeutics management will join two live online talks this month - Stock Titan

Relay Therapeutics (RLAY) Insider Peter Rahmer Sells 4,508 Shares - GuruFocus

Relay Therapeutics (RLAY) exec sells 4,508 shares under plan - Stock Titan

SoftBank Vision Fund Subsidiary Sells 6 Million Shares of Relay Therapeutics at $19.4 Each - Kalkine Media

Relay Therapeutics director SVF Pauling (Cayman) sells $116.4m By Investing.com - Investing.com Canada

Simile a RLAY

ABCL$12.118.90%

TNGX$23.839.49%

XENE$38.853.27%

ARQT$32.102.69%

EWTX$37.740.98%